Bacterial Vaginosis Market Epidemiology Report 2025-2035: Drug Pipeline, Treatment, Trends, Rising Incidence & prevalence The report also provides a detailed analysis of the current bacterial ...

Women's vaginal discharge is not normal if it has an unpleasant odor, itching, or pain during sexual intercourse and ...

The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis . 2007 Nov;34(11):864-9. doi: 10.1097 ...

Women's health innovator Evofem Biosciences, Inc. (OTCPK: EVFM) today announced that a study of SOLOSEC® (secnidazole) 2 g oral granules for recurrent bacterial vaginosis (BV) presented at the ...

Bacterial vaginosis (BV) is a condition characterized by a loss of the indigenous vaginal lactobacilli and massive anaerobic overgrowth of the vaginal mucosa with a mix of anaerobes.

Introduction. Bacterial vaginosis (BV) is a condition characterized by the partial loss of the indigenous vaginal lactobacilli on the one hand, and massive polymicrobial anaerobic overgrowth of ...

Precisio will use its proprietary AI/ML-guided Zeus ™-LysiThru™ platform technologies to discover engineered lysins with superior activity and specificity with funding support from the Gates ...

And here in Ghana? According to a 2024 multi-country analysis of Performance Monitoring for Action (PMA) data, 34.2 per cent ...

Valentina Milanova, founder of Daye, believes that for years, we’ve been using outdated and ill-matched technology to test for viruses and pathogens that cause women’s health issues. Daye’s diagnostic ...

Precisio Biotix Therapeutics, Inc. (Precisio) Announces a Grant for the Discovery of Novel Engineered Lysin Antimicrobials Targeting Bacterial Vaginosis Associated Pathobionts (BV) ...